* = joint first authors.

Vasikasin V, Rawson TM, Holmes AH, Otter JA. Can precision antibiotic prescribing help prevent the spread of carbapenem resistant organisms in the hospital setting? J Antimicrob Chemother 2023 in press.
Rochon M, Jawarchan A, Fagan F, Otter JA, Tanner J. Image-based digital post-discharge surveillance in England: measuring patient enrolment, engagement, clinician response times, surgical site infection and carbon footprint. J Hosp Infect. 2023 in press.

Otter JA*, Zhou J*, Price JR, Reeves L, Zhu N, Randell P, Sriskandan S, Barclay W, Holmes AH. SARS-CoV-2 surface and air contamination in an acute healthcare setting during the first and second pandemic waves. J Hosp Infect 2023 in press.

Otter JA, Newsholme W, Snell LB, Merrick B, Okeke N, Mack DJF, Breathnach AS, Price NM. Evaluation of clinical harm associated with Omicron hospital-onset COVID-19 infection.  J Infect 2023;86:66-117.

Robinson J, Price L, Otter JA, Burnett E. Designing an optimal infection prevention service: Part 2. J Infect Prevent 2023;24:11-22.

Zhu NJ, Rawson TM, Mookerjee S, Price JR, Davies F, Otter JA, Aylin P, Hope R, Gilchrist M, Shersing Y, Holmes A. Changing Patterns of Bloodstream Infections in the Community and Acute Care Across 2 Coronavirus Disease 2019 Epidemic Waves: A Retrospective Analysis Using Data Linkage. Clin Infect Dis. 2022 Aug 24;75(1):e1082-e1091.

Ledwoch K, Dancer SJ, Otter JA, Maillard JY. Dirty QWERTY: there’s no ESC! J Hosp Infect. 2021 Nov;117:184-185. 

Graves N, Mitchell BG, Otter JA, Kiernan M. The cost effectiveness of temporary single rooms to reduce the risk of healthcare-associated infection. J Hosp Infect 2021; 116: 21-28.

Abbas M, Zhu NJ, Mookerjee S, Bolt F, Otter JA, Holmes AH, Price JR. Hospital-onset COVID-19 infection surveillance systems: A systematic review. J Hosp Infect 20211;15:44-50. 

Ledwoch K, Dancer SJ, Otter JA, Kerr K, Roposte D, Maillard J-Y. How dirty is your QUERTY? The risk of healthcare pathogen transmission from computer keyboards. J Hosp Infect 2021;112:31-36.

Martischang R, Tartari E, Kilpatrick C, Mackenzie G, Carter V, Castro-Sánchez E, Márquez-Villarreal H, Otter JA, Perencevich E, Silber D, Storr J, Tetro J, Voss A, Pittet D. Enhancing engagement beyond the conference walls: analysis of Twitter use at #ICPIC2019 infection prevention and control conference. Antimicrob Resist Infect Control. 2021;10:20.

Castro-Sánchez E, Alexander CM, Atchison C, Patel D, Leung W, Calamita M, Meno Garcia D, Cimpeanu C, Mumbwatasai JM, Ramid D, Doherty K, Grewal HS, Otter JA, Wells M. Evaluation of a personal protective equipment (PPE) support programme (‘PPE Helpers’) for staff during the COVID-19 pandemic in London. J Hosp Infect 2021;109:68-77.

Otter JA, Mookerjee S, Davies F, Bolt F, Dyakova E, Shersing Y, Boonjasiri A, Weise AY, Gilchrist M, Galletly TJ, Brannigan ET, Holmes A. Detecting CPE – an evaluation of an enhanced CPE infection control and screening programme in acute care. J Antimicrob Chemother 2020;75:2670-2676.

Zhou J*, Otter JA*, Price JR, Cimpeanu C, Meno Garcia D, Kinross J, Boshier P, Mason S, Bolt F, Holmes AH, Barklay W. Investigating SARS-CoV-2 surface and air contamination in an acute healthcare setting during the peak of the COVID-19 pandemic in London. Clin Infect Dis 2021;73:e1870-e1877.

Price JR*, Mookerjee S*, Dyakova E, Myall A, Leung W, Weiße AY, Shersing Y, Brannigan ET, Galletly T, Muir D, Randell P, Davies F, Bolt F, Barohona M, Otter JA, Holmes AH. Development and delivery of a real-time hospital-onset COVID-19 surveillance system using network analysis. Clin Infect Dis 2021;72:82-89.

Rodriguez-Manzano J, Moser N, Malpartida-Cardenas K, Moniri A, Fisarova L, Pennisi I, Boonyasiri A, Jauneikaite E, Abdolrasouli A, Otter JA, Bolt F, Davies F, Didelot X, Holmes A, Georgiou P. Rapid Detection of Mobilized Colistin Resistance using a Nucleic Acid Based Lab-on-a-Chip Diagnostic System. Sci Rep 2020;21;10(1):8448.

Peters A, Parneix P, Otter JA, Pittet D. Putting some context to the aerosolization debate around SARS-CoV-2. J Hosp Infect 2020;105:381-382.

Gordon J, Darlington O, McEwan P, Lumley M, Taie A, Hicks M, Charbonneau C, Blake A, Hawkins N, Goldenberg S, Otter JA, Wilcox M. Estimating the Value of New Antimicrobials in the Context of Antimicrobial Resistance: Development and Application of a Dynamic Disease Transmission Model. Pharmacoeconomics 2020;38:857-869.

Birgand G, Mutter NT, Ahmad R, Tacconelli E, Lucet J-C, Holmes AH, Percept-R Study Group. Risk perception of the antimicrobial resistance by infection control specialists in Europe: a case-vignette study. Antimicrob Resist Infect Control 2020;19:33.

Ellington MJ, Davies F, Jauneikaite E, Hopkins KL, Turton JF, Adams G, Pavlu J, Innes AJ, Eades C, Brannigan ET, Findlay J, White L, Bolt F, Kadhani T, Chow Y, Patel B, Mookerjee S, Otter JA, Sriskandan S, Woodford N, Holmes AH. A multi-species cluster of GES-5 carbapenemase producing Enterobacterales linked by a geographically disseminated plasmid. Clin Infect Dis accepted.

Birgand G, Troughton R, Marino V, Campbell A, Hettiaratchy S, Hopkins S, Otter JA, Holmes AH. How do surgeons feel about the “Getting it Right First Time” national audit? Results from a qualitative assessment. J Hosp Infect 2020;104:328-331.

Vink J, Otter JA, Edgeworth JD. Carbapenemase-Producing Enterobacteriaceae – once positive always positive? Current Opinion Gastroenterol 2019 [Epub ahead of print].

Otter JA. How far can improving environmental hygiene REACH in preventing healthcare-associated infections? Lancet Infect Dis 2019;19:345-347.

Otter JA, Natale A, Batra R, Tosas Auguet O, Dyakova E, Goldenberg SD, Edgeworth JD. Individual and community-level risk factors for ESBL Enterobacteriaceae colonization identified by universal admission screening in London. Clin Microbiol Infect 2019;25:1259-1265.

Patel A, Parikh P, Dunn AN, Otter JA, Thota P, Fraser TG, Donskey CJ, Deshpande A. Effectiveness of daily chlorhexidine bathing for reducing gram-negative infections: A meta-analysis. Infect Control Hosp Epidemiol 2019;40:392-399.

Ming DK, Otter JA, Ghani R, Brannigan ET, Boonyasiri A, Mookerjee S, Gilchrist M, Holmes AH, Davies F. The Clinical Risk Stratification and Antibiotic Management of NDM and OXA-48 carbapenemase-producing Enterobacteriaceae bloodstream infections the United Kingdom. J Hosp Infect 2019;102:95-9.

Mizuno S, Iwami M, Kunisawa S, Naylor N, Yamashita K, Kyratsis Y, Meads G, Otter JA, Holmes AH, Imanaka Y, Ahmad R. Comparison of national strategies to reduce meticillin-resistant Staphylococcus aureus infections in Japan and England. J Hosp Infect 2018;100:280-298.

Marbach H, Vizcay-Barrena G, Memarzadeh K, Otter JA, Pathak S, Allaker RP, Edgeworth JD, Harvey RDTolerance of MRSA ST239-TW to chlorhexidine-based decolonization; evidence for keratinocyte invasion as a mechanism of biocide evasion. J Infect 2019;78:119-126.

Knight GM, Dyakova E, Mookerjee S, Davies F, Brannigan ET, Otter JA, Holmes AH. Fast and expensive (PCR) or cheap and slow (culture)? A mathematical modelling study to explore screening for carbapenem resistance in UK hospitals. BMC Med 2018;16:141.

Otter JA, Galletly T, Davies F, Hitchcock J, Gilchrist M, Dyakova E, Mookerjee S, Holmes AH, Brannigan ET. Planning to halve GNBSI: getting to grips with healthcare-associated Escherichia coli bloodstream infection sources. J Hosp Infect 2018;101:129-133.

Ledwoch K, Dancer SJ, Otter JA, Kerr K, Roposte D, Maillard JY. Beware Biofilm! Dry biofilms containing bacterial pathogens on multiple healthcare surfaces; a multicentre study. J Hosp Infect 2018;100:e47-e56.

Mookerjee S, Dyakova E, Davies F, Bamford K, Brannigan ET, Holmes A, Otter JA. Evaluating the benefit of serial screening cultures to detect carbapenemase-producing Enterobacteriaceae (CPE) following hospital admission. J Hosp Infect 2018;100:15-20.

Nellums LB, Thompson H, Holmes A, Castro-Sánchez E, Otter JA, Norredam M, Friedland JS, Hargreaves S. Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis. Lancet Infect Dis 2018: S1473-3099(18)30219-6.

Hawkey PM, Warren RE, Livermore DM, McNulty CAM, Enoch DA, Otter JA, Wilson APR. Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party. J Antimicrob Chemother 2018;73(Suppl 3):iii2-iii78.

Tosas Auget O, Stabler RA, Betley J, Preston MD, Dhaliwal M, Gaunt M, Ioannou A, Desai N, Keradag T, Batra R, Otter JA, Marbach H, Clark TG, Edgeworth JD. Frequent undetected MRSA ward-based transmission linked to patient sharing between hospitals. Clin Infect Dis 2018;66:840-848. 

Otter JA, Doumith M, Davies F, Mookerjee S, Dyakova E, Gilchrist M, Brannigan ET, Bamford K, Galletly T, Donaldson H, Aanensen DM, Ellington MJ, Hill R, Turton JF, Hopkins KL, Woodford N, Holmes A. Emergence and clonal spread of colistin resistance due to multiple mutational mechanisms in carbapenemase-producing Klebsiella pneumoniae in London. Sci Rep 2017;7:12711.

Mitchell BG, Russo PL, Otter JA, Kiernan M, Aveling L. What makes a tweet fly? Analysis of twitter messaging from four infection control conferences. Infect Control Hosp Epidemiol 2017;38:1271-1276.

Weber DJ, Otter JA, Rutala WA. Can Copper Coated Surfaces Prevent Healthcare-Associated Infections? Infect Control Hosp Epidemiol 2017;38:772-776.

Dyakova E, Bisnauthsing KN, Querol-Rubiera A, Patel A, Ahanonu C, Tosas Auguet O, Edgeworth JD, Goldenberg SD, Otter JA. Efficacy and acceptability of rectal and perineal sampling for identifying gastrointestinal colonisation with ESBL-Enterobacteriaceae. Clin Microbiol Infect 2017;23:577.e1-577.e3.

Marbach H, Boakes E, Lynham S, Ward M, Otter JA, Edgeworth JD. Identification of a distinctive phenotype for endocarditis-associated clonal complex 22 MRSA isolates with reduced vancomycin susceptibility. J Med Microbiol 2017 66:584-591.

Keward J, Bradshaw P, Otter JA. Reducing the number of missed isolation days in a paediatric high-dependency unit using semi-permanent pods. J Infect Prevent 2017;18:67–71.

Otter JA, Burgess P, Davies F, Mookerjee S, Gilchrist M, Parsons D, Brannigan ET, Robotham JV, Holmes AH. Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: an economic evaluation from a hospital perspective. Clin Microbiol Infect 2017;23:188-196.

Boakes E, Marbach H, Lynham S, Ward M, Edgeworth JD, Otter JA. A comparative analysis of Phenol Soluble Modulin production and G. mellonella killing by community-associated and healthcare-associated MRSA strains. J Med Microbiol 2016;65:1429-1433.

Otter JA, Dyakova E, Bisnauthsing K, Querol-Rubiera A, Patel A, Ahanonu C, Tosas Auguet O, Edgeworth J, Goldenberg S. Universal hospital admission screening for carbapenemase-producing organisms in a low prevalence setting. J Antimicrobial Chemother 2016;71:3556-3561.

McCord J, Prewitt M, Dyakova E, Mookerjee S, Otter JA. Reduction in Clostridium difficile infection (CDI) associated with the introduction of hydrogen peroxide vapor (HPV) automated room disinfection. J Hosp Infect 2016;94:185-187.

Otter JA. Interpreting the guidelines for cleaning up after carbapenamse-producing organisms: the devil’s in the dilution. J Hosp Infect 2016;94:108-109.

Vella V, Moore LSP, Robotham J, Davies F, Birgand GJC, Otter JA, Brannigan E, Dyakova E, Knight GM, Mookerjee S, Holmes AH. Vella V, Moore LSP, Robotham J, Davies F, Birgand GJC, Otter JA, Brannigan E, Dyakova E, Knight GM, Mookerjee S, Holmes AH. Demand and capacity for carbapenemase-producing Enterobacteriaceae screening in a West London hospital network. J Hosp Infect 2016;94:118-124.

Brown C, Livermore DM, Otter JA, Warren RE, Jenks P, Enoch DA, Newsholme W, Oppenheim B, Leanord A, McNulty C, Tanner G, Bennett S, Cann M, Bostock J, Collins E, Peckitt S, Ritchie L, Fry C, Hawkey P, Wilson AP. Multidrug-resistant (MDR) Gram-negative bacteria information leaflets. J Hosp Infect 2016;92:86-87.

Tosas Auguet O, Betley J, Patel A, Marbach H, Stabler R, Hern P, Ayree A, Otter JA, Goldenberg SD, Desai N, Karadag T, Grundy C, Gaunt M, Cooper B, Edgeworth J, Kypraios T. Evidence for community transmission of community-associated but not health-care-associated methicillin-resistant Staphylococcus aureus strains linked to social and material deprivation: spatial analysis of cross-sectional data. Plos Med 2016;13:e1001944.

Horn K, Otter JA. Hydrogen peroxide vapor room disinfection and hand hygiene improvements reduce Clostridium difficile infection, MRSA, VRE and ESBL by 47%. Am J Infect Control 2015;43:1354-1356.

Wilson APR, Livermore DM, Otter JA, Warren RE, Jenks P, Enoch DA, Newsholme, Oppenheim B, Leanord A, McNulty C, Tanner G, Bennett S, Cann M, Bostock J, Collins E, Peckitt S, Ritchie L, Fry C, Hawkey PM. Prevention and control of multiresistant Gram-negative bacteria – recommendations from a Joint Working Party. J Hosp Infect 2016 Jan;Suppl 1:S1-S44.

Hughes J, Goldenberg SD, Tosas O, Edgeworth JD, Otter JA. Recent emergence of carbapenem-resistant organisms in a low prevalence UK setting in London. J Infect Prevent 2016;17:130-134.

Otter JA. Reflections from Infection Prevention 2015: beating the bugs, improving the systems and thinking outside the box. J Infect Prevent 2016;17:3741.

Otter JA, Donskey CJ, Yezli S, Douthwaite S, Goldenberg SD, Weber DJ. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp Infect 2016;92:235-250.

Otter JA, Mepham S, Athan B, Mack D, Smith R, Jacobs M, Hopkins S. Terminal decontamination of the Royal Free London High Level Isolation Unit (HLIU) following a case of Ebola virus disease using hydrogen peroxide vapour. Am J Infect Control 2016;44:233-235.

Fisher D, Long P, Salmon S, Teo C, Cook A, Otter JA. Where’s all the VRE gone? A successful VRE bundle at a Singapore hospital. Infect Control Hosp Epidemiol 2016;37:107-109.

Otter JA, Mutters N, Tacconelli E, Gikas A, Holmes AH. Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries. Clin Microbiol Infect 2015;21:1057-1066.

Otter JA. Biofilms mean that the ‘environmentome’ of hospital surfaces is teeming with life. J Hosp Infect 2015;91:218-219.

Otter JA. The inaugural Healthcare Infection Society Middle East Summit: ‘No action today. No cure tomorrow. J Hosp Infect 2015;91:199-201.

Hughes J, Stabler R, Karadag T,  Desai N, Patel A, Otter JA, Edgeworth JD, Tosas Auguet O. Clonal variation in high- and low-level phenotypic and genotypic mupirocin resistance of MRSA isolates in South East London. J Antimicrobial Chemother 2015;70:3191-3199.

Biswas J, Patel A, Otter JA, van Kleef E, Goldenberg SD. Significant contamination of the hospital environment from potential Clostridium difficile excretors. Infect Control Hosp Epidemiol 2015;36:975-977.

Biswas J, Patel A, Otter JA, Wade P, Newsholme W, Goldenberg SD. Reduction in Clostridium difficile environmental contamination in hospitalised patients treated with fidaxomicin. J Hosp Infect 2015;90:267-270.

Otter JA. What’s trending in the infection prevention and control literature? From HIS 2012 to HIS 2014, and beyond. J Hosp Infection 2015;89:229-236.

Lemmen S, Scheithauer S, Häfner H, Yezli S, Mohr M, Otter JA. Evaluation of hydrogen peroxide vapour for the inactivation of nosocomial pathogens on porous and non-porous surfaces. Am J Infect Control 2015;43:82-85.

Otter JA, Vickery K, Walker J, deLancey-Pulcini E, Stoodley P, Salkeld JA, Chewins J, Yezli S, Edgeworth JD. Surface-attached cells, biofilms and biocide susceptibility: implications for hospital cleaning and disinfection. J Hosp Infect 2015;89:16-27.

Yezli S, Otter JA. Does the inanimate environment play a role in the transmission of pathogens in operating room? Surg Infect 2014;15:694-699.

Curran E, Otter JA. How to prevent and control outbreaks of carbapenem-resistant Enterobacteriaceae. J Infect Prevent 2014;15:193-198.

Otter JA, Tosas O, Herdman MT, Williams B, Tucker D, Edgeworth JD, French GL. Implications of targeted versus universal admission screening for meticillin-resistant Staphylococcus aureus carriage in a London hospital. J Hosp Infect 2014;87:171-174.

O’Halloran PD, Winter PK, Otter JA, Adams NMT, Chewins J. Aqueous oxygen peroxide treatment of venous leg ulcers is associated with improved wound healing in a primary care based randomised, double-blind, placebo-controlled trial. J Wound Care 2014;23:176-190.

Goyal SM, Chander Y, Yezli S, Otter JA. Evaluating the virucidal efficacy of hydrogen peroxide vapor (HPV). J Hosp Infect 2014;86:255-259.

Otter JA, Davies B, Menson E, Klein JL, Watts TL, Kearns AM, Pichon B, Edgeworth JD, French GL. Identification and control of a gentamicin-resistant, meticillin-susceptible Staphylococcus aureus outbreak on a neonatal unit. J Infect Prevent 2014;15:104-109.

Havill NL, Boyce JM, Otter JA. Extended survival of carbapenem-resistant Enterobacteriaceae on dry surfaces. Infect Control Hosp Epidemiol 2014;35:445-447.

Otter JA. Infection Prevention 2013 – a potted overview. J Infect Prevent 2014;15:9.

Otter JA, Yezli S, Perl TM, Barbut F, French GL. A request for an alliance in the battle for clean and safe hospital surfaces. J Hosp Infect 2013;84:341-342.

Otter JA, Nowakowski E, Salkeld JAG, Duclos M, Passaretti CL, Yezli S, Ross T, Carroll KC, Perl TM. Saving costs through the decontamination of the packaging of unused medical supplies using hydrogen peroxide vapor. Infect Control Hosp Epidemiol 2013;34:472-478.

Otter JA, Yezli S, Salkeld JAG, French GL. Evidence that contaminated surfaces contribute to the transmission of hospital pathogens and an overview of strategies to address contaminated surfaces in hospital settings. Am J Infect Control 2013;41:S6-S11.

Barbut F, Yezli S, Otter JA. Hydrogen peroxide room disinfection: there is no elephant in the room but there’s plenty of evidence in the trunk. J Hosp Infect 2013;83:355-356.

Otter JA, Patel A, Cliff P, Halligan E, Tosas O, Edgeworth JD. Selection for qacA carriage in CC22 but not CC30 MRSA bloodstream infection isolates during a successful institutional infection control programme. J Antimicrob Chemother 2013;68:992-999.

Otter JA, Herdman MT, Williams B, Tosas O, Edgeworth JD, French GL. Low prevalence of meticillin-resistant Staphylococcus aureus carriage at hospital admission: implications for risk factor based vs. universal screening. J Hosp Infect 2013;83:114-121.

Otter JA. How do we tackle contaminated hospital surfaces? Healthcare Infect 2013;18:42-44.

Otter JA, Yezli S, Perl TM, Barbut F, French GL. The role of ‘no-touch’ automated room disinfection systems in infection prevention and control. J Hosp Infect 2013;83:1-13.

Passaretti CL, Otter JA, Reich NG, Myers J, Shepard J, Howard T, Carroll KC, Lipsett P, Perl TM. Environmental decontamination with hydrogen peroxide vapor reduces the risk of patient acquisition of multidrug-resistant organisms. Clin Infect Dis 2013;56:27-35.

Barbut F, Yezli S, Mimoun M, Pham J, Chaouat M, Otter JA. Reducing the spread of Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus on a burns unit through the intervention of an infection control bundle. Burns 2013;39:395-403.

Otter JA. Hospital infection control in 2012: new solutions for old and resurgent problems. J Healthcare Associated Infect 2012;5:68-72.

Otter JA, Yezli S, French GL. The impact of the suspending medium on the susceptibility of meticillin-resistant Staphylococcus aureus to hydrogen peroxide vapour (HPV) decontamination. J Hosp Infect 2012;82:213-215.

Yezli S, Otter JA. Does the discovery of biofilms on dry hospital environmental surfaces change the way we think about hospital disinfection? J Hosp Infect 2012;81:293-294.

Otter JA, French GL. Community-associated meticillin-resistant Staphylococcus aureus: the case for a genotypic definition. J Hosp Infect 2012;81:143-8. [Selected as one of the top 10 papers of the year by the editor:]

Otter JA, Yezli S. Are commercially available Geobacillus stearothermophilus biological indicators an appropriate standard for hydrogen peroxide vapour systems in hospitals? J Hosp Infect 2012;80:272-273.

Miller CE, Batra R, Copper BS, Patel AK, Klein J, Otter JA, Kypraios T, French GL, Tosas O, Edgeworth JD. An association between bacterial genotype combined with a high-vancomycin minimum inhibitory concentration and risk of endocarditis in methicillin-resistant Staphylococcus aureus bloodstream infection. Clin Infect Dis 2012;54:591-600.

Barbut F, Yezli S, Otter JA. The in vitro activity of hydrogen peroxide vapour (HPV) against Clostridium difficile spores. J Hosp Infect 2012;80:85-87.

Otter JA, French GL. Community-associated meticillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated infection. J Hosp Infect 2011;79:189-193.

Yezli S, Otter JA. Minimum infective dose of the major human respiratory and enteric viruses transmitted through food and the environment: a review. Food Environ Virol 2011;3:1-30.

Otter JA, Yezli S, French GL. The role of contaminated surfaces in the transmission of nosocomial pathogens. Infect Control Hosp Epidemiol 2011;32:687-699.

Berrie E, Andrews L, Yezli S, Otter JA. Hydrogen peroxide vapour (HPV) inactivation of adenovirus. Lett Applied Micro 2011;52:555-558.

Cooper T, O’Leary M, Yezli S, Otter JA. The impact of environmental decontamination using hydrogen peroxide vapour on the incidence of Clostridium difficile infection in one hospital trust. J Hosp Infect 2011;78:238-240.

Otter JA, French GL. Utility of antimicrobial susceptibility based algorithms for the presumptive identification of genotypically-defined community-associated methicillin-resistant Staphylococcus aureus at a London teaching hospital. Eur J Clin Microbiol Infect Dis 2011;30:459-463.

Otter JA, Yezli S. A call for clarity when discussing hydrogen peroxide vapour and aerosol systems. J Hosp Infect 2011;77:83-84.

Otter JA, Passaretti CL, Ross T, Carroll KC, French GL, Perl TM. Low frequency of environmental contamination with methicillin-resistant Staphylococcus aureus in an inner city emergency department and an HIV outpatient clinic. Am J Infect Control 2011;39:151-153.

Otter JA, Havill NL, Boyce JM. Hydrogen peroxide vapor is not the same as aerosolized hydrogen peroxide. Infect Control Hosp Epidemiol 2010;11:1201-1202.

Otter JA, Yezli S, Schouten MA, van Zanten ARH, Houmes-Zielman G, Nohlmans-Paulssen. Hydrogen peroxide vapor (HPV) decontamination of an intensive care unit to remove environmental reservoirs of multidrug-resistant Gram-negative rods during an outbreak. Am J Infect Control 2010;38:754-756.

Otter JA, Yezli S. Cycle times for hydrogen peroxide vapour decontamination. Can J Microbiol 2010;56:356-257.

Otter JA, Barnicoat M, Down J, Smyth D, Yezli S, Jeanes A. Hydrogen peroxide vapour (HPV) decontamination of an intensive care unit room used to treat a patient with Lassa fever. J Hosp Infect 2010;75:335-337.

Otter JA, French GL. The molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe. Lancet Infect Dis 2010;10:227-239.

Otter JA, Kearns AM, French GL, Ellington MJ. Panton-Valentine leukocidin encoding bacteriophage and gene sequence variation in community-associated methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 2010;16:68-73.

Otter JA, French GL. Bacterial contamination on touch surfaces in the public transport system and in public areas of a hospital in London. Lett Appl Microbiol 2009;49:803-805.

Otter JA, Havill NL, Adams NMT, Cooper TC, Tauman A, Boyce JM. Environmental sampling for Clostridium difficile: swabs or sponges? Am J Infect Control 2009;37:517-518.

Otter JA, Puchowicz M, Ryan D, Salkeld JA, Cooper TA, Havill NL, Tuozzo K, Boyce JM. Feasibility of routinely using hydrogen peroxide vapor to decontaminate rooms in a busy United States hospital. Infect Control Hosp Epidemiol 2009;30:574-547.

Otter JA, Budde-Niekiel A. Hydrogen peroxide vapor: a novel method for the environmental control of lactococcal bacteriophages. J Food Prot 2009;72:412-414.

Otter JA, Havill NL, Boyce JM, French GL. Comparison of community-associated meticillin-resistant Staphylococcus aureus from teaching hospitals in London and the USA, 2004-2006: where is USA300 in the UK? Eur J Clin Microbiol Infect Dis 2009;28:835-839.

Otter JA, French GL. Survival of nosocomial bacteria and spores on surfaces and inactivation by hydrogen peroxide vapour (HPV). J Clin Microbiol 2009;47:205-207.

Boyce JM, Havill NL, Otter JA, McDonald LC, Adams NM, Thompson A, Wiggs L, Noble-Wang J. Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect Cont Hosp Epidemiol 2008;29:723-729.

Otter JA, French GL. The emergence of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) at a London Teaching Hospital, 2000-2006. Clin Microbiol Infect 2008;14:670-676.

Otter JA, French GL. Community-associated meticillin-resistant Staphylococcus aureus in injecting drug users and the homeless in south London. J Hosp Infect 2008;69:198-200.

Dryden M, Parnaby R, Dailly S, Lewis T, Davis-Blues K, Otter JA, Kearns AM. Hydrogen peroxide vapor (HPV) decontamination in the control of a polyclonal MRSA outbreak on a surgical ward. J Hosp Infect 2008;68:190-192.

Hall L, Otter JA, Chewins J, Wengenack NL. Deactivation of the dimorphic fungi Histoplasma capsulatum, Blastomyces dermatitidis and Coccidioides immitis using hydrogen peroxide vapor. Med Mycol 2008;46:189-191.

Otter JA, Chewins J, Windsor D, Windsor H. Microbial contamination in cell culture: a potential role for hydrogen peroxide vapour (HPV)? Cell Biol Int 2008;32:326-327.

Otter JA, Klein J, Watts T, Kearns AM, French GL. Identification and control of an outbreak of ciprofloxacin-susceptible EMRSA-15 on a neonatal unit. J Hosp Infect 2007;67:232-239.

Otter JA, Cummins M, Ahmad F, van Tonder C, Drabu YJ. Assessing the biological efficacy and rate of recontamination following hydrogen peroxide vapour decontamination. J Hosp Infect 2007;67:182-188.

Boyce JM, Havill NL, Otter JA, Adams NM. Widespread environmental contamination associated with patients with diarrhea and methicillin-resistant Staphylococcus aureus colonization of the gastrointestinal tract. Infect Control Hosp Epidemiol 2007; 28:1142-1147.

Otter JA, Havill NL, Boyce JM. Evaluation of real-time polymerase chain reaction for detection of methicillin-resistant Staphylococcus aureus on environmental surfaces. Infect Cont Hosp Epidemiol 2007;28:1003-1005.

Hall L, Otter JA, Chewins J, Wengenack NL. Use of hydrogen peroxide vapour for deactivation of Mycobacterium tuberculosis in a biological safety cabinet and a room. J Clin Microbiol 2007;45:810-815.

Otter JA, French GL. Nosocomial transmission of community-associated methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2006;6:753-755.

Otter JA, French GL, Adams NM, Watling D, Parks MJ. Hydrogen peroxide vapour decontamination in an overcrowded tertiary care referral centre: some practical answers. J Hosp Infect 2006;62:384-385.

Otter JA. Bio-deactivation of hospital pathogens. Health Estate 2005;59:41-44.

Johnston MD, Lawson S, Otter JA. Evaluation of hydrogen peroxide vapour as a method for the decontamination of surfaces contaminated with Clostridium botulinum spores. J Microbiol Methods 2005;60:403-411.

French GL, Otter JA, Shannon KP, Adams NM, Watling D, Parks MJ. Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. J Hosp Infect 2004;57:31-37.